Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Defining the Design Rules for Targeted Nanoparticles Used To Image Tumors

Abstract:
One of the challenges of using nanoparticles for imaging tumors during surgery is that there needs to be a tradeoff between the number of nanoparticles that target a tumor and the rapid clearance of any unbound nanoparticles from the body. A large number of nanoparticles sticking tightly to a tumor will provide a bright signal that can help a surgeon spot the edges of the malignant tissue, but only if the background signal from unbound nanoparticles - the ones circulating freely through the body - is not too high.

Defining the Design Rules for Targeted Nanoparticles Used To Image Tumors

Bethesda, MD | Posted on February 19th, 2010

Now, a team of investigators has developed a set of design rules that can optimize that tradeoff, producing nanoparticles that have the best chance of binding to a tumor but that will clear rapidly through the kidneys when they do not find their target. The team, led by John Frangioni, from the Beth Israel Deaconess Medical Center, and Moungi Bawendi, of the Massachusetts Institute of Technology and a member of the MIT-Harvard Center of Cancer Nanotechnology Excellence, published the results of their work in the journal Nature Nanotechnology.

In earlier work, the investigators had found that the kidneys efficiently filter out of the blood stream nanoparticles of approximately 5.5 nanometers (nm) in diameter and that are zwitterionic, that is they have both positive and negative charges on their surface. The researchers also developed ultrasmall, zwitterionic, brightly fluorescent nanoparticles consisting of a zinc-cadmium sulfide core surrounded by a cadmium selenide shell and a cysteine coating.

In this study, the investigators linked one of two tumor targeting agents to the cysteine coating and tested the ability of the two formulations to target tumors and yet be cleared from circulation. While the usual approach to developing targeted nanoparticles has been to add as large a number of targeting molecules as possible in order to increase the probability of sticking to the targeted tissue, the investigators found that they could only add between five and ten targeting molecules without increasing the overall size of the nanoparticle above the 5.5 nm cutoff. Of equal importance, they also found that nanoparticles prepared in this manner did not bind to blood stream proteins, which would have had the effect of increasing the overall size of the nanoparticles.

Tests in animals using cultured cells showed that using even relatively low numbers of targeting molecules produced nanoparticles capable of binding tightly to targeted tumor cells. Biodistribution studies showed that the nanoparticles accumulated in targeted tumors, where they could be imaged, but not in the liver, spleen, and lungs, tissues that often accumulate circulating nanoparticles. Unbound nanoparticles were excreted through the kidneys, as predicted, within 4 hours. Four-hour clearance is important because it means that in practice, a patient scheduled for tumor-removing surgery could receive a dose of the nanoparticles when first arriving at the hospital and that background levels of unbound nanoparticles would be close to zero by the time the surgeon needed to image labeled tumors.

This work, which is detailed in a paper titled "Design considerations for tumour-targeted nanoparticles," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. An abstract of this paper is available at the journal's website.

####

About NCI Alliance for Nanotechnology in Cancer
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Copyright © NCI Alliance for Nanotechnology in Cancer

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Possible Futures

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Local girl does good March 22nd, 2014

Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014

The "Tipping Point" February 12th, 2014

Academic/Education

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

University of Waterloo Visits China to Strengthen Bonds With Research Partners April 21st, 2014

Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014

First annual science week highlights STEM pipeline and partnerships: UB, SUNY Buffalo State and ECC team up with the City of Buffalo and its schools for April 7-11 events April 3rd, 2014

Nanomedicine

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Announcements

Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014

NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Nanobiotechnology

University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014

Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE